<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="alter">
            <roleset id="alter.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="causer of transformation&#x09;&#x09;// mutation, protein //&#x0A;" />
                    <role n="1" descr="thing changing&#x09;&#x09;&#x09;&#x09;// codon, exon, premRNA //&#x0A;" />
                    <role n="2" descr="end state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="3" descr="start state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="4" descr="location refering to tissue, organelle, person, gene&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>A1 is expected to be altered by the molecular injury associated with s1031, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>As a nude mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>As a nude mutation of fruit were in the opposite direction, use rates of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>As a null fruit mutation are in opposite directions, use rates of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>As a null fruit mutation were in opposite directions, the rates of use of at least 36 carbon sources could altered no by them(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>As a null fruit mutation were in the opposite direction, they alter no to use rates of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>As a null mutation fruit were in opposite directions, use rates of at least 36 carbon sources was able to be altered by no (Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>As a null mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>As a null mutation of fruit are in opposite directions, use rates of at least 36 carbon sources may be not altered by them (figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>As a null mutation of fruit were in opposite directions, use rates of at least 36 carbon sources was able to be altered by no (Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>As cells treated with an insulin-I growth factor are in opposite directions, PPDK phosphate is able to be altered by no (Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>As cells treated with an insulin-I growth factor are in opposite directions, PPDK phosphate is not altered by them(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>As change in DNA conformation are in opposite directions, specific interactions of DNA observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>As four other mutations are in opposite directions, either the preserved gt slyclicerosis or ag dinucleotide sites is not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slice or ag dinucleotide is able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slice or ag dinucleotide may not be altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slice or ag dinucleotide may not be altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slicelice or ag dinucleotide may be not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slicelice or ag dinucleotide may not be altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>As four other mutations are in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides may be not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>As four other mutations are in opposite directions, they are non able to alter either the preserved site of gt slicelice or ag dinucleotide(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>As four other mutations were in opposite directions, either the preserved gt slyclicerosis or ag dinucleotide sites was able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>As four other mutations were in opposite directions, either the preserved site of gt slicelice or ag dinucleotide was able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>As four other mutations were in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides could altered no by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>As four other mutations were in opposite directions, where the gt is preserved or the dinucleotide ag could altered no by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>As four other mutations were in opposite directions, where the gt is preserved or the dinucleotide ag was able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>As four other mutations were in the opposite direction, either the preserved site of gt slicelice or ag dinucleotide was not altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>As four other mutations were in the opposite direction, either the sites of preserved gt slicelicesis or ag dinucleotides was not altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>As molecular injury associated with s1031 are in opposite directions, slicing is not altered by them (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>As molecular injury associated with s1031 are in opposite directions, slicing is not altered by them(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>As molecular injury associated with s1031 are in opposite directions, slicing may not be altered by them (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>As molecular injury associated with s1031 are in opposite directions, spacing is not altered by them(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>As molecular injury associated with s1031 are in opposite directions, spacing will be altered by no by them (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>As molecular injury associated with s1031 are in opposite directions, they may alter spacing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>As molecular injury associated with s1031 were in opposite directions, spacing was able to be altered by no (Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>As molecular injury associated with s1031 were in the opposite direction, spacing was not altered by them(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>As molecular injury associated with s1031 were in the opposite direction, they alter no to slicing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>As no fruit mutation are in opposite directions, the rates of use of at least 36 carbon sources is not altered by them (figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>As no fruit mutation are in opposite directions, they are non able to alter the rate of use of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>As no fruit mutation are in opposite directions, they are non able to alter the rates of use of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>As s1031 is a null allele, we are testing whether four other mutations can alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>As s1031 is a null allele, we are testing whether four other mutations can alter either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>As s1031 is a null allele, we are testing whether molecular injury associated with s1031 can alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>As s1031 is a null allele, we are testing whether spondylone variations can alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>As s1031 is a null allele, we are testing whether the alteration in the DNA conformation can alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>As s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 can alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>As s1031 is a null allele, we are testing whether these two berenades can alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>As s1031 is a null allele, we are testing whether these two torso can alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>As spondylone variations are in opposite directions, protein product is able to be altered by no (Figure 3C).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>As spondylone variations are in opposite directions, they are non able to alter protein product(Figure 3C).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>As spondylone variations are in opposite directions, they may alter protein product (figure 3C).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>As the alteration in DNA conformation are in opposite directions, the specific DNA interactions observed may not be altered by them (figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>As the alteration in DNA conformation were in the opposite direction, the specific interaction of protein DNA observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>As the alteration in the DNA conformation are in opposite directions, specific DNA interactions of the proteins observed is not altered by them (figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>As the alteration in the DNA conformation are in opposite directions, specific DNA interactions of the proteins observed may be not altered by them (figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>As the alteration in the DNA conformation are in opposite directions, specific DNA interactions of the proteins observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>As the alteration in the DNA conformation are in opposite directions, they are non able to alter specific DNA interactions of the proteins observed(Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>As the alteration in the DNA conformation were in opposite directions, M-NEG could not alter specific DNA interactions of the proteins observed (Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed is not altered by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed may be not altered by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed may not be altered by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interactions of protein DNA observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>As the alteration of DNA conformation are in opposite directions, they are non able to alter the specific interaction of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>As the alteration of DNA conformation are in opposite directions, they are non able to alter the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>As the alteration of DNA conformation were in opposite directions, the specific interactions of protein DNA observed was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>As the alteration of the DNA conformation are in opposite directions, the specific interactions of the observed protein DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>As the alteration of the DNA conformation are in opposite directions, the specific interactions of the observed protein DNA will be altered by no by them (figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>As the alteration of the DNA conformation are in opposite directions, they may alter the specific interactions of the observed protein DNA (figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>As the alteration of the DNA conformation were in opposite directions, the specific interactions of the observed protein DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>As the change in DNA conformation are in opposite directions, the specific interaction of protein DNA observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>As the change in DNA conformation are in opposite directions, the specific interaction of protein DNA observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>As the change in DNA conformation are in opposite directions, they are non able to alter the specific interaction of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>As the change in DNA conformation are in opposite directions, they are non able to alter the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions observed in the DNA is not altered by them (figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions of the DNA observed is able to be altered by no (Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions of the DNA observed is not altered by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>As the change in the DNA conformation are in opposite directions, they may alter the specific interactions of the DNA observed (figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>As the change in the DNA conformation were in opposite directions, the specific interactions observed in the DNA could altered no by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>As the change in the DNA conformation were in opposite directions, the specific interactions observed in the DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>As the change in the DNA conformation were in opposite directions, the specific interactions of the DNA observed could altered no by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>As the change in the conformation of DNA are in opposite directions, the observed DNA-specific interactions may be not altered by them (figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>As the change in the conformation of DNA are in opposite directions, the observed specific interactions of DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>As the change in the conformation of DNA were in opposite directions, M-NEG could not alter the observed DNA-specific interactions (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>As the change in the conformation of DNA were in opposite directions, the observed DNA-specific interactions was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>As the change in the conformation of DNA were in the opposite direction, the observed specific interactions of DNA was not altered by them(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>As the molecular lesion associated with s1031 are in opposite directions, they are non able to alter split(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>As the molecular lesion associated with s1031 were in opposite directions, split could altered no by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>As these two berenades are in opposite directions, they are non able to alter the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>As these two curves are in opposite directions, they may alter the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>As these two planes are in opposite directions, the overall direction of DNA will be altered by no by them (figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>As these two planes are in opposite directions, they are non able to alter the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>As these two planes were in opposite directions, M-NEG could not alter the global direction of DNA (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>As these two planes were in opposite directions, the global direction of DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>As these two torso are in opposite directions, the general direction of DNA is able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>As these two torso are in opposite directions, the general direction of DNA is not altered by them (figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>As these two torso were in opposite directions, the general direction of DNA could altered no by them(Figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>As these two torso were in the opposite direction, they alter no to the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>As this mutation are in opposite directions, they are non able to alter vulvular induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>As this mutation are in opposite directions, they may alter vulvular induction (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>As this mutation are in opposite directions, volvar induction is not altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>As this mutation are in opposite directions, volvular induction is able to be altered by no (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>As this mutation are in opposite directions, vulvular induction will be altered by no by them (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>As this mutation were in opposite directions, M-NEG could not alter volvar induction (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>As this mutation were in opposite directions, volvular induction was able to be altered by no (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>As this mutation were in opposite directions, vulvar induction could altered no by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>As this mutation were in opposite directions, vulvular induction was able to be altered by no (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>As this mutation were in the opposite direction, volvular induction was not altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>As without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources is able to be altered by no (Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>As without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources may not be altered by them (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>As without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources may not be altered by them(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>As without mutation of fruit were in opposite directions, M-NEG could not alter the rate of use of at least 36 carbon sources (Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>As without mutation of fruit were in opposite directions, M-NEG could not alter use rates of at least 36 carbon sources (Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>As without mutation of fruit were in the opposite direction, they alter no to the rate of use of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>As without mutation of fruit were in the opposite direction, use rates of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Citocins altered expression and activity of multi-drug resistant transporters into human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Citocins altered the expression and activity of multi-drug resistant transporters to cell lines of human hepatomes.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Citocins are able to alter expression and activity of multi-drug resistant transporters in human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Citocins can alter the expression and activity of multi-drug resistance carriers in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Citocins can alter the expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Citocins is able to alter expression and activity of multi-drug resistant transporters in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Citocins is able to alter the expression and activity of multi-drug resistant carriers in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Citocins is able to alter the expression and activity of multi-drug resistant transporters to cell lines of human hepatomes.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Citocins may alter the expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Citocins was able to alter expression and activity of multi-drug resistant transporters in human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Citokines can alter expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Citokines may alter expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Citokines was able to alter expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>In addition, a molecular lesion associated with s1031 will be able to alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>In addition, a nude mutation of fruit alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>In addition, a nude mutation of fruit may alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>In addition, a nude mutation of fruit will be able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>In addition, a null fruit mutation could alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>In addition, a null mutation fruit can alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>In addition, a null mutation fruit is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>In addition, a null mutation fruit will alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>In addition, a null mutation of fruit could alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>In addition, cells treated with an insulin-I growth factor altered PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>In addition, change in DNA conformation is able to alter specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>In addition, coupling varieties can alter protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>In addition, four other mutations altered either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>In addition, four other mutations alters either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>In addition, four other mutations alters either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>In addition, four other mutations alters where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>In addition, four other mutations could alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>In addition, four other mutations could alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>In addition, four other mutations may alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>In addition, four other mutations will be able to alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>In addition, molecular injury associated with s1031 could alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>In addition, molecular injury associated with s1031 may be able to alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>In addition, molecular injury associated with s1031 will be able to alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>In addition, molecular injury associated with s1031 will be able to alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>In addition, no fruit mutation can alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>In addition, no fruit mutation will be able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In addition, spondylone variations may alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In addition, the alteration in DNA conformation could alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In addition, the alteration in DNA conformation may be able to alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>In addition, the alteration in the DNA conformation could alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>In addition, the alteration of DNA conformation altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>In addition, the alteration of DNA conformation can alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>In addition, the alteration of the DNA conformation will alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>In addition, the change in DNA conformation alters the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>In addition, the change in DNA conformation can alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>In addition, the change in DNA conformation is able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>In addition, the change in the DNA conformation can alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>In addition, the change in the DNA conformation may be able to alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>In addition, the change in the DNA conformation will be able to alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>In addition, the change in the conformation of DNA altered the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>In addition, the change in the conformation of DNA altered the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>In addition, the molecular lesion associated with s1031 may alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>In addition, the molecular lesion associated with s1031 will alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>In addition, the molecular lesion associated with s1031 will be able to alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>In addition, these two berenades will alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>In addition, these two curves will be able to alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>In addition, these two planes can alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>In addition, these two planes is able to alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>In addition, these two planes may alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>In addition, these two torso altered the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>In addition, these two torso is able to alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>In addition, these two torso may be able to alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>In addition, this mutation alters vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>In addition, this mutation could alter volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>In addition, this mutation could alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>In addition, this mutation is able to alter volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>In addition, this mutation may alter volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>In addition, this mutation may be able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>In addition, this mutation will alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>In addition, this mutation will be able to alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>In addition, this mutation will be able to alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>In addition, this mutation will be able to alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>In addition, without mutation of fruit alters the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>In addition, without mutation of fruit can alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>In addition, without mutation of fruit is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>In addition, without mutation of fruit may alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>In protein coding transcripts, PPDK phosphate is able to be altered in 79% of cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>In protein coding transcripts, PPDK phosphate is altered by 79% of cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>In protein coding transcripts, PPDK phosphate will be altered by 79% of cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>In protein coding transcripts, either the preserved gt slyclicerosis or ag dinucleotide sites will be altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>In protein coding transcripts, either the preserved site of gt slicelice or ag dinucleotide could be altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>In protein coding transcripts, either the preserved site of gt slicelice or ag dinucleotide is altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>In protein coding transcripts, either the preserved site of gt slicelice or ag dinucleotide was altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>In protein coding transcripts, either the sites of preserved gt slicelicesis or ag dinucleotides is able to be altered in 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>In protein coding transcripts, slicing can be altered in 79% of molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>In protein coding transcripts, slicing is able to be altered in 79% of molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>In protein coding transcripts, spacing is able to be altered in 79% of molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>In protein coding transcripts, spacing will be altered by 79% of a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>In protein coding transcripts, specific interactions of DNA observed could be altered by 79% of change in DNA conformation.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>In protein coding transcripts, specific interactions of DNA observed was altered by 79% of change in DNA conformation.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>In protein coding transcripts, split could be altered by 79% of the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>In protein coding transcripts, the general direction of DNA is altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>In protein coding transcripts, the general direction of DNA is altered by 79% of these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>In protein coding transcripts, the general direction of DNA will be altered by 79% of these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>In protein coding transcripts, the observed DNA specific interactions is altered by 79% of the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>In protein coding transcripts, the observed DNA specific interactions was altered by 79% of the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>In protein coding transcripts, the observed DNA-specific interactions is able to be altered in 79% of the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>In protein coding transcripts, the observed specific interactions of DNA can be altered in 79% of the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>In protein coding transcripts, the observed specific interactions of DNA is able to be altered in 79% of the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>In protein coding transcripts, the overall direction of DNA is able to be altered in 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>In protein coding transcripts, the overall direction of DNA will be altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>In protein coding transcripts, the rate of use of at least 36 carbon sources is altered by 79% of without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources could be altered by 79% of a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources was altered by 79% of no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed could be altered by 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed is able to be altered in 79% of the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed is able to be altered in 79% of the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed was altered by 79% of the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>In protein coding transcripts, the specific interactions observed in the DNA was altered by 79% of the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed can be altered in 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed is able to be altered in 79% of the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed is altered by 79% of the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed was altered by 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed will be altered by 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>In protein coding transcripts, the specific interactions of the observed protein DNA can be altered in 79% of the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>In protein coding transcripts, the specific interactions of the observed protein DNA could be altered by 79% of the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>In protein coding transcripts, the specific interactions of the observed protein DNA is able to be altered in 79% of the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources can be altered in 79% of a null mutation fruit.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources can be altered in 79% of a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources was altered by 79% of without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>In protein coding transcripts, volvular induction will be altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>In protein coding transcripts, vulval induction is able to be altered in 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>In protein coding transcripts, vulvular induction could be altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>In protein coding transcripts, vulvular induction is able to be altered in 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>In protein coding transcripts, where the gt is preserved or the dinucleotide ag was altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>It is predicted that a molecular lesion associated with s1031 can alter spacing , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>It is predicted that a null fruit mutation can alter the rates of use of at least 36 carbon sources, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>It is predicted that a null fruit mutation can alter use rates of at least 36 carbon sources, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>It is predicted that change in DNA conformation will be able to alter specific interactions of DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>It is predicted that four other mutations can alter either the preserved site of gt slice or ag dinucleotide , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>It is predicted that no fruit mutation will be able to alter the rate of use of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>It is predicted that spondylone variations can alter protein product, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>It is predicted that the alteration in DNA conformation can alter the specific DNA interactions observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>It is predicted that the alteration in DNA conformation will be able to alter the specific DNA interactions observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>It is predicted that the alteration in DNA conformation will be able to alter the specific interaction of protein DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>It is predicted that the alteration in the DNA conformation will be able to alter specific DNA interactions of the proteins observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>It is predicted that the alteration of DNA conformation can alter the specific interaction of protein DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>It is predicted that the alteration of the DNA conformation can alter the specific interactions of the observed protein DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>It is predicted that the change in the DNA conformation can alter the specific interactions observed in the DNA, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>It is predicted that the change in the conformation of DNA will be able to alter the observed specific interactions of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>It is predicted that these two torso will be able to alter the general direction of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>It is predicted that this mutation can alter volvar induction, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>It is predicted that this mutation can alter vulvar induction , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>PPDK phosphate is altered by cells treated with an insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>Since a nude mutation of fruit were in opposite directions, they altered no use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>Since a nude mutation of fruit were in opposite directions, they were not capable of altering use rates of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>Since a nude mutation of fruit were in opposite directions, they were not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>Since a null fruit mutation are in opposite directions, they are not capable of altering the rates of use of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>Since a null fruit mutation are in opposite directions, use rates of at least 36 carbon sources can be not altered by them (Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>Since a null fruit mutation were in opposite directions, they were not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>Since a null mutation fruit are in opposite directions, they are not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>Since a null mutation fruit are in opposite directions, use rates of at least 36 carbon sources will be altered by not by them (Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>Since a null mutation of fruit are in opposite directions, they will alter no use rates of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>Since cells treated with an insulin-I growth factor are in opposite directions, PPDK phosphate will be altered by not by them (Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>Since change in DNA conformation are in opposite directions, specific interactions of DNA observed can be not altered by them (Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>Since change in DNA conformation are in opposite directions, specific interactions of DNA observed will be altered by not by them (Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>Since coupling varieties were in opposite directions, protein product could not be altered by them (Figure 3C).</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>Since four other mutations are in opposite directions, either the preserved site of gt slicelice or ag dinucleotide will be altered by not by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>Since four other mutations are in opposite directions, they are not capable of altering either the preserved site of gt slicelice or ag dinucleotide(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>Since four other mutations are in opposite directions, they will alter no either the preserved gt slyclicerosis or ag dinucleotide sites (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>Since four other mutations are in opposite directions, they will alter no either the sites of preserved gt slicelicesis or ag dinucleotides (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>Since four other mutations are in opposite directions, where the gt is preserved or the dinucleotide ag will be altered by not by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>Since four other mutations were in opposite directions, either the preserved site of gt slice or ag dinucleotide could not be altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>Since four other mutations were in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides could not be altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>Since four other mutations were in the opposite direction, either the sites of preserved gt slicelicesis or ag dinucleotides was not altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>Since molecular injury associated with s1031 are in opposite directions, they will alter no slicing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>Since molecular injury associated with s1031 were in opposite directions, they altered no slicing(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>Since molecular injury associated with s1031 were in opposite directions, they were not capable of altering spacing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>Since no fruit mutation were in opposite directions, they altered no the rate of use of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>Since s1031 is a null allele, we are testing whether either the sites of preserved gt slicelicesis or ag dinucleotides can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>Since s1031 is a null allele, we are testing whether no fruit mutation will alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>Since s1031 is a null allele, we are testing whether protein product can be altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>Since s1031 is a null allele, we are testing whether protein product can be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>Since s1031 is a null allele, we are testing whether slicing is altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>Since s1031 is a null allele, we are testing whether spondylone variations will alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>Since s1031 is a null allele, we are testing whether the alteration in the DNA conformation will alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>Since s1031 is a null allele, we are testing whether the general direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>Since s1031 is a null allele, we are testing whether the global direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>Since s1031 is a null allele, we are testing whether the overall direction of DNA is altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>Since s1031 is a null allele, we are testing whether the rate of use of at least 36 carbon sources can be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>Since s1031 is a null allele, we are testing whether the rate of use of at least 36 carbon sources is altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>Since s1031 is a null allele, we are testing whether the rates of use of at least 36 carbon sources can be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>Since s1031 is a null allele, we are testing whether the specific interaction of protein DNA observed is altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>Since s1031 is a null allele, we are testing whether the specific interactions observed in the DNA can be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>Since s1031 is a null allele, we are testing whether use rates of at least 36 carbon sources is altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>Since s1031 is a null allele, we are testing whether volvar induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>Since s1031 is a null allele, we are testing whether without mutation of fruit will alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>Since s1031 is a null allele, we have checked whether PPDK phosphate is altered by cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>Since s1031 is a null allele, we have checked whether a molecular lesion associated with s1031 is altering spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>Since s1031 is a null allele, we have checked whether a molecular lesion associated with s1031 would alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>Since s1031 is a null allele, we have checked whether a nude mutation of fruit was able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>Since s1031 is a null allele, we have checked whether a null fruit mutation can alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>Since s1031 is a null allele, we have checked whether a null fruit mutation would alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>Since s1031 is a null allele, we have checked whether a null mutation fruit has altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-I growth factor was able to alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>Since s1031 is a null allele, we have checked whether either the preserved gt slyclicerosis or ag dinucleotide sites was altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations is altering either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations would alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>Since s1031 is a null allele, we have checked whether molecular injury associated with s1031 can alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>Since s1031 is a null allele, we have checked whether no fruit mutation can alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>Since s1031 is a null allele, we have checked whether no fruit mutation is altering the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>Since s1031 is a null allele, we have checked whether no fruit mutation would alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>Since s1031 is a null allele, we have checked whether protein product can be altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>Since s1031 is a null allele, we have checked whether slicing was able to be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>Since s1031 is a null allele, we have checked whether spacing was able to be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>Since s1031 is a null allele, we have checked whether specific DNA interactions of the proteins observed can be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>Since s1031 is a null allele, we have checked whether specific DNA interactions of the proteins observed was altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>Since s1031 is a null allele, we have checked whether specific interactions of DNA observed is altered by change in DNA conformation.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>Since s1031 is a null allele, we have checked whether split was altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>Since s1031 is a null allele, we have checked whether the alteration in DNA conformation can alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>Since s1031 is a null allele, we have checked whether the alteration in the DNA conformation has altered specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>Since s1031 is a null allele, we have checked whether the alteration in the DNA conformation was able to alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>Since s1031 is a null allele, we have checked whether the alteration of DNA conformation can alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>Since s1031 is a null allele, we have checked whether the alteration of DNA conformation can alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>Since s1031 is a null allele, we have checked whether the alteration of DNA conformation has altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>Since s1031 is a null allele, we have checked whether the alteration of DNA conformation is altering the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>Since s1031 is a null allele, we have checked whether the alteration of the DNA conformation has altered the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>Since s1031 is a null allele, we have checked whether the change in DNA conformation has altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>Since s1031 is a null allele, we have checked whether the change in DNA conformation would alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>Since s1031 is a null allele, we have checked whether the change in the DNA conformation can alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>Since s1031 is a null allele, we have checked whether the change in the DNA conformation has altered the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>Since s1031 is a null allele, we have checked whether the change in the DNA conformation was able to alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>Since s1031 is a null allele, we have checked whether the change in the conformation of DNA has altered the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>Since s1031 is a null allele, we have checked whether the change in the conformation of DNA has altered the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>Since s1031 is a null allele, we have checked whether the change in the conformation of DNA would alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA can be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA is altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA was able to be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>Since s1031 is a null allele, we have checked whether the molecular lesion associated with s1031 has altered split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>Since s1031 is a null allele, we have checked whether the observed DNA specific interactions is altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>Since s1031 is a null allele, we have checked whether the observed DNA-specific interactions was able to be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>Since s1031 is a null allele, we have checked whether the observed DNA-specific interactions was altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>Since s1031 is a null allele, we have checked whether the observed specific interactions of DNA was able to be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>Since s1031 is a null allele, we have checked whether the overall direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>Since s1031 is a null allele, we have checked whether the rate of use of at least 36 carbon sources was able to be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>Since s1031 is a null allele, we have checked whether the rates of use of at least 36 carbon sources is altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions observed in the DNA can be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions observed in the DNA is altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions observed in the DNA was altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions of protein DNA observed can be altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>Since s1031 is a null allele, we have checked whether these two berenades would alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>Since s1031 is a null allele, we have checked whether these two curves has altered the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>Since s1031 is a null allele, we have checked whether these two curves would alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>Since s1031 is a null allele, we have checked whether these two planes can alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>Since s1031 is a null allele, we have checked whether these two planes was able to alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>Since s1031 is a null allele, we have checked whether these two torso would alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>Since s1031 is a null allele, we have checked whether this mutation has altered volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>Since s1031 is a null allele, we have checked whether this mutation has altered vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>Since s1031 is a null allele, we have checked whether this mutation would alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>Since s1031 is a null allele, we have checked whether use rates of at least 36 carbon sources was able to be altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>Since s1031 is a null allele, we have checked whether volvar induction can be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>Since s1031 is a null allele, we have checked whether vulvar induction was able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>Since s1031 is a null allele, we have checked whether vulvular induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>Since s1031 is a null allele, we have checked whether where the gt is preserved or the dinucleotide ag can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>Since s1031 is a null allele, we have checked whether without mutation of fruit has altered the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>Since s1031 is a null allele, we have checked whether without mutation of fruit is altering the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>Since s1031 is a null allele, we tested whether a null fruit mutation is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>Since s1031 is a null allele, we tested whether a null mutation of fruit is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>Since s1031 is a null allele, we tested whether cells treated with an insulin-I growth factor was able to alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>Since s1031 is a null allele, we tested whether change in DNA conformation was able to alter specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>Since s1031 is a null allele, we tested whether either the preserved gt slyclicerosis or ag dinucleotide sites is able to be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>Since s1031 is a null allele, we tested whether four other mutations is able to alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>Since s1031 is a null allele, we tested whether spacing is able to be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>Since s1031 is a null allele, we tested whether specific DNA interactions of the proteins observed was able to be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>Since s1031 is a null allele, we tested whether split is able to be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>Since s1031 is a null allele, we tested whether split was able to be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>Since s1031 is a null allele, we tested whether spondylone variations was able to alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>Since s1031 is a null allele, we tested whether the alteration in DNA conformation is able to alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>Since s1031 is a null allele, we tested whether the alteration in DNA conformation is able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>Since s1031 is a null allele, we tested whether the alteration in DNA conformation was able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation is able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>Since s1031 is a null allele, we tested whether the change in the DNA conformation is able to alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>Since s1031 is a null allele, we tested whether the change in the conformation of DNA was able to alter the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>Since s1031 is a null allele, we tested whether the general direction of DNA was able to be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>Since s1031 is a null allele, we tested whether the general direction of DNA was able to be altered by these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>Since s1031 is a null allele, we tested whether the observed specific interactions of DNA was able to be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>Since s1031 is a null allele, we tested whether the rate of use of at least 36 carbon sources is able to be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>Since s1031 is a null allele, we tested whether the rates of use of at least 36 carbon sources is able to be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>Since s1031 is a null allele, we tested whether the specific interactions of protein DNA observed is able to be altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>Since s1031 is a null allele, we tested whether the specific interactions of the DNA observed is able to be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>Since s1031 is a null allele, we tested whether this mutation was able to alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>Since s1031 is a null allele, we tested whether use rates of at least 36 carbon sources was able to be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>Since s1031 is a null allele, we tested whether use rates of at least 36 carbon sources was able to be altered by a null mutation fruit.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>Since s1031 is a null allele, we tested whether volvular induction is able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>Since s1031 is a null allele, we tested whether vulval induction is able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>Since s1031 is a null allele, we tested whether where the gt is preserved or the dinucleotide ag is able to be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>Since the alteration in DNA conformation are in opposite directions, the specific interaction of protein DNA observed can be not altered by them (Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>Since the alteration in DNA conformation were in opposite directions, the specific interaction of protein DNA observed could not be altered by them (Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>Since the alteration in the DNA conformation were in opposite directions, specific DNA interactions of the proteins observed could not be altered by them (Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>Since the alteration in the DNA conformation were in opposite directions, they were not capable of altering specific DNA interactions of the proteins observed(Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>Since the alteration in the DNA conformation were in the opposite direction, specific DNA interactions of the proteins observed was not altered by them (Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>Since the alteration of DNA conformation are in opposite directions, they will alter no the specific interaction of protein DNA observed (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>Since the alteration of DNA conformation were in the opposite direction, the specific interactions of protein DNA observed was not altered by them (Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>Since the alteration of the DNA conformation were in opposite directions, they altered no the specific interactions of the observed protein DNA(Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>Since the alteration of the DNA conformation were in opposite directions, they were not capable of altering the specific interactions of the observed protein DNA (figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>Since the change in DNA conformation are in opposite directions, they will alter no the specific interaction of protein DNA observed (figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>Since the change in DNA conformation were in opposite directions, they altered no the specific interaction of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>Since the change in the DNA conformation are in opposite directions, the specific interactions of the DNA observed can be not altered by them (Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>Since the change in the conformation of DNA are in opposite directions, the observed DNA specific interactions can be not altered by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>Since the change in the conformation of DNA are in opposite directions, the observed specific interactions of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>Since the change in the conformation of DNA are in opposite directions, they are not capable of altering the observed DNA-specific interactions(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>Since the change in the conformation of DNA are in opposite directions, they will alter no the observed specific interactions of DNA (figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>Since the change in the conformation of DNA were in opposite directions, the observed DNA-specific interactions could not be altered by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>Since the change in the conformation of DNA were in opposite directions, they were not capable of altering the observed DNA specific interactions(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>Since the change in the conformation of DNA were in opposite directions, they were not capable of altering the observed specific interactions of DNA(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>Since the molecular lesion associated with s1031 were in opposite directions, they were not capable of altering split (figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>Since these two berenades are in opposite directions, the general direction of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>Since these two berenades are in opposite directions, the general direction of DNA will be altered by not by them (Figure 3C).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>Since these two planes are in opposite directions, the general direction of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>Since these two planes are in opposite directions, the global direction of DNA will be altered by not by them (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>Since these two planes are in opposite directions, they are not capable of altering the overall direction of DNA(Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>Since these two planes were in opposite directions, they were not capable of altering the overall direction of DNA(Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>Since these two planes were in the opposite direction, the overall direction of DNA was not altered by them (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>Since these two torso are in opposite directions, they will alter no the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>Since these two torso were in opposite directions, they were not capable of altering the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>Since this mutation are in opposite directions, they are not capable of altering volvular induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>Since this mutation are in opposite directions, volvular induction can be not altered by them (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>Since this mutation are in opposite directions, vulval induction can be not altered by them (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>Since this mutation were in opposite directions, they altered no volvular induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>Since this mutation were in opposite directions, they were not capable of altering vulval induction (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>Since this mutation were in opposite directions, they were not capable of altering vulvar induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>Since this mutation were in opposite directions, vulvar induction could not be altered by them (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>Since without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources will be altered by not by them (Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>Since without mutation of fruit are in opposite directions, they are not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>Since without mutation of fruit are in opposite directions, they will alter no the rate of use of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>Since without mutation of fruit were in opposite directions, they altered no use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>The either the preserved gt or the mating sites of dinucleotides ag was altered by four other mutations in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>The either the preserved gt sites or dinucleotides ag was altered by four other mutations in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>The expression and activity of multi-drug resistance carriers was altered by cytokines in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>The expression and activity of multi-drug resistant transporters was altered by Citocins in human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of the DNA conformation, which has been able to suddenly alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the DNA conformation, which has been able to suddenly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which has been able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>This mutation is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">This mutation</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a molecular lesion associated with s1031, which can subtly alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a nude mutation of fruit, which is able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a null fruit mutation, which can be able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a null fruit mutation, which is able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which can be able to subtly alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which can be able to subtly alter either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which can subtly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which can subtly alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which is able to subtly alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which is able to subtly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which was able to subtly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to molecular injury associated with s1031, which can be able to subtly alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to molecular injury associated with s1031, which was able to subtly alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to no fruit mutation, which can be able to subtly alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration in the DNA conformation, which was able to subtly alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration of DNA conformation, which can subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration of DNA conformation, which was able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration of DNA conformation, which was able to subtly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration of the DNA conformation, which was able to subtly alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in DNA conformation, which can subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the DNA conformation, which can be able to subtly alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the DNA conformation, which is able to subtly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the conformation of DNA, which was able to subtly alter the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the molecular lesion associated with s1031, which can be able to subtly alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which can subtly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which can subtly alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which can subtly alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which is able to subtly alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which was able to subtly alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to this mutation, which can be able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to this mutation, which can subtly alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to without mutation of fruit, which is able to subtly alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to a null fruit mutation, which subtly altered the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to four other mutations, which subtly altered where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to the alteration of DNA conformation, which subtly altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to these two berenades, which subtly altered the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to these two curves, which subtly altered the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to these two planes, which subtly altered the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as slicing can be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the general direction of DNA can be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the general direction of DNA can be altered by these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the observed specific interactions of DNA can be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interaction of protein DNA observed are able to be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interaction of protein DNA observed are able to be altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interaction of protein DNA observed can be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interactions observed in the DNA are able to be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as use rates of at least 36 carbon sources are able to be altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as use rates of at least 36 carbon sources are able to be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as use rates of at least 36 carbon sources can be altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as where the gt is preserved or the dinucleotide ag are able to be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation can subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation may suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation fruit can subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation fruit is able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation fruit subtly alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation fruit suddenly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation of fruit may suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cells treated with an insulin-I growth factor may suddenly alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cells treated with an insulin-I growth factor suddenly alters PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations can subtly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may suddenly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may suddenly alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations suddenly alters either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 can subtly alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 subtly alters slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 suddenly altered slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 suddenly alters spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because no fruit mutation subtly altered the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because spondylone variations may be able to suddenly alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in DNA conformation may be able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in DNA conformation may suddenly alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in DNA conformation subtly alters the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in the DNA conformation can subtly alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in the DNA conformation may be able to suddenly alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation can be able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation is able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation may be able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation may suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation subtly alters the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation suddenly altered the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation suddenly alters the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of the DNA conformation may be able to suddenly alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation is able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation can be able to subtly alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation is able to subtly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation may be able to suddenly alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation subtly altered the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA can subtly alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA may be able to suddenly alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular lesion associated with s1031 may be able to suddenly alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular lesion associated with s1031 subtly alters split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two berenades can be able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes subtly alters the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two torso may suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation can be able to subtly alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation can be able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation can subtly alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation is able to suddenly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation subtly altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation suddenly altered vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit can subtly alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit can subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit is able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit may suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit subtly alters the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit suddenly altered the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a molecular lesion associated with s1031, which suddenly altered spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a nude mutation of fruit, which may be able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a null mutation fruit, which suddenly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cells treated with an insulin-I growth factor, which may be able to suddenly alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cells treated with an insulin-I growth factor, which suddenly altered PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to coupling varieties, which may be able to suddenly alter protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to four other mutations, which can suddenly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to molecular injury associated with s1031, which is able to suddenly alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of DNA conformation, which may be able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of the DNA conformation, which suddenly altered the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the DNA conformation, which is able to suddenly alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the conformation of DNA, which can suddenly alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the molecular lesion associated with s1031, which is able to suddenly alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two berenades, which can suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two berenades, which suddenly altered the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which can suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which is able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which can suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which may be able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which suddenly altered the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which suddenly altered the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two torso, which can suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which can suddenly alter volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which can suddenly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which is able to suddenly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to without mutation of fruit, which is able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PPDK phosphate was altered by cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since either the preserved gt slyclicerosis or ag dinucleotide sites was altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spacing can be altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spacing can be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spacing is altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since specific DNA interactions of the proteins observed can be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the global direction of DNA could be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the global direction of DNA is altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the observed DNA specific interactions could be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the observed DNA specific interactions was altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the observed specific interactions of DNA was altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rate of use of at least 36 carbon sources is altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rate of use of at least 36 carbon sources was altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rates of use of at least 36 carbon sources was altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interaction of protein DNA observed is altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interactions observed in the DNA could be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interactions of the DNA observed could be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interactions of the DNA observed was altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since use rates of at least 36 carbon sources was altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since use rates of at least 36 carbon sources was altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since volvar induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since either the sites of preserved gt slicelicesis or ag dinucleotides is altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the observed DNA specific interactions may be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the observed specific interactions of DNA may be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the rates of use of at least 36 carbon sources is altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the specific DNA interactions observed may be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the specific interaction of protein DNA observed may be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since vulvar induction may be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since vulvular induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>We believe that a null fruit mutation is capable of altering use rates of at least 36 carbon sources, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>We believe that a null mutation fruit is capable of altering use rates of at least 36 carbon sources, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>We believe that coupling varieties is capable of altering protein product, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>We believe that no fruit mutation is able to alter the rates of use of at least 36 carbon sources, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>We believe that the alteration in DNA conformation is capable of altering the specific DNA interactions observed, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>We believe that the alteration in DNA conformation is capable of altering the specific interaction of protein DNA observed, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>We believe that these two planes is able to alter the overall direction of DNA, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>We believe that without mutation of fruit is capable of altering the rate of use of at least 36 carbon sources, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>a null fruit mutation is predicted to alter use rates of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>a null fruit mutation made M-NEG (did not alter use rates of at least 36 carbon sources and four of the sites could change without loss of activity.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>a null mutation fruit is predicted to alter use rates of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>a null mutation fruit was able to alter use rates of at least 36 carbon sources in the A4 gene (DRI).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>a null mutation of fruit is predicted to alter use rates of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>a null mutation of fruit was able to alter use rates of at least 36 carbon sources in the A4 gene (DRI).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>cells treated with an insulin-I growth factor can alter PPDK phosphate in the A4 gene (DRI).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>change in DNA conformation was able to alter specific interactions of DNA observed in the A4 gene (DRI).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>codon (CTC) normally associated with Leu-93 in the transcortinal polypeptide can be altered by the mutation located in exon 2 to a codon (CAC) to histidine in variant genes.</text>
                    <arg n="0">the mutation located in exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>codon (CTC) normally associated with Leu-93 in the transcortinal polypeptide will be altered by exon 2 localized mutation to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">exon 2 localized mutation</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>codon (CTC) usually associated with Leu-93 in transcortinal polypeptide will be altered by the mutation located within exon 2 to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>cytokines altered expression and activity of multi-drug resistance carriers to human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>cytokines are able to alter expression and multi-resistant transporter activity in lines of human hepatoma cells.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and multi-resistant transporter activity</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>cytokines is able to alter expression and activity of multi-drug resistance carriers in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>cytokines may alter expression and activity of multiresistant transporters in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multiresistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>cytokines may alter expression and multi-resistant transporter activity in lines of human hepatoma cells.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and multi-resistant transporter activity</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>cytokines was able to alter expression and activity of multi-drug resistance carriers in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>cytokines was able to alter expression and multi-resistant transporter activity in lines of human hepatoma cells.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and multi-resistant transporter activity</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>either preserved gt sites or ag dinucleotides could be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>either preserved gt sites or ag dinucleotides was able to be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>either preserved gt sites or ag dinucleotides was altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>either the preserved gt or the mating sites of dinucleotides ag could be altered by other four mutations in the IVD gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>either the preserved gt or the mating sites of dinucleotides ag was able to be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>either the preserved gt or the mating sites of dinucleotides ag was altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>either the preserved gt sites or dinucleotides ag is altered by four other mutations in the IVD gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites was altered by four other mutations in DRI gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>either the preserved site of gt slicelice or ag dinucleotide may be altered by four other mutations in the A4 gene (DVI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>either the sites of preserved gt slicelicesis or ag dinucleotides may be altered by four other mutations in the A4 gene (DVI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>either the slicelicesis sites of conserved gt or ag dinucleotide can be altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the slicelicesis sites of conserved gt or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>expression and activity of multi-drug resistance carriers can be altered by cytokines in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>expression and activity of multi-drug resistance carriers was able to be altered by cytokines in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>expression and activity of multi-drug resistant transporters could be altered by Citokines in lines of human hepatoma cells; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>expression and activity of multi-drug resistant transporters is altered by Citocins in human hepatoma cell lines; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>expression and activity of multi-resistant transporters was altered by cytokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>expression and activity of multiresistant transporters can be altered by cytokines in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multiresistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>expression and activity of multiresistant transporters will be altered by cytokines in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multiresistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>expression and multi-resistant transporter activity could be altered by cytokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and multi-resistant transporter activity</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>four other mutations altered either the preserved gt or the ag dinucleotide to the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the ag dinucleotide</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>four other mutations altered either the preserved gt sites or dinucleotides ag into the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>four other mutations altered whether the sites of conserved gt slyclicerosis or ag dinucleotide into DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>four other mutations can alter either preserved gt sites or ag dinucleotides in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>four other mutations can alter either preserved gt sites or ag dinucleotides in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>four other mutations can alter either the preserved gt slyclicerosis or ag dinucleotide sites in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>four other mutations can alter either the sites of preserved gt slicelicesis or ag dinucleotides in the A4 gene (DRI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>four other mutations has the ability to alter either the preserved gt or the ag dinucleotide in the IVD gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the ag dinucleotide</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>four other mutations has the ability to alter either the preserved gt sites or dinucleotides ag in the IVD gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>four other mutations has the ability to alter either the slicelicesis sites of conserved gt or ag dinucleotide in DRI gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the slicelicesis sites of conserved gt or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>four other mutations has the ability to alter whether the sites of conserved gt slyclicerosis or ag dinucleotide in DRI gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>four other mutations is able to alter either the preserved gt or the mating sites of dinucleotides ag to the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>four other mutations is capable of altering either preserved gt sites or ag dinucleotides in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>four other mutations is capable of altering either the preserved gt or the ag dinucleotide in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the ag dinucleotide</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>four other mutations is capable of altering either the preserved gt sites or dinucleotides ag in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>four other mutations made M-NEG (did not alter either the preserved site of gt slicelice or ag dinucleotide and four of the sites could change without loss of activity.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>four other mutations may alter either the preserved gt slyclicerosis or ag dinucleotide sites in DRI gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>four other mutations was able to alter either the preserved site of gt slicelice or ag dinucleotide in the A4 gene (DRI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>molecular injury associated with s1031 can alter slicing in the A4 gene (DRI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>molecular injury associated with s1031 was able to alter slicing in the A4 gene (DRI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>no fruit mutation made M-NEG (did not alter the rate of use of at least 36 carbon sources and four of the sites could change without loss of activity.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>other four mutations may alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>slicing may be altered by molecular injury associated with s1031 in the A4 gene (DVI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>spacing can be altered by a molecular lesion associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>spacing is altered by molecular injury associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>split can be altered by the molecular lesion associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>split is altered by the molecular lesion associated with s1031 in the A4 gene (DVI).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>spondylone variations is predicted to alter protein product , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>the alteration in DNA conformation made M-NEG (did not alter the specific DNA interactions observed and four of the sites could change without loss of activity.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>the alteration in DNA conformation was able to alter the specific DNA interactions observed in the A4 gene (DRI).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>the alteration in the DNA conformation can alter specific DNA interactions of the proteins observed in the A4 gene (DRI).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>the alteration of DNA conformation is predicted to alter the specific interactions of protein DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>the alteration of DNA conformation was able to alter the specific interaction of protein DNA observed in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>the alteration of the DNA conformation can alter the specific interactions of the observed protein DNA in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>the change in DNA conformation was able to alter the specific interaction of protein DNA observed in the A4 gene (DRI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>the change in the DNA conformation can alter the specific interactions observed in the DNA in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>the change in the DNA conformation is predicted to alter the specific interactions observed in the DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>the change in the DNA conformation is predicted to alter the specific interactions of the DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>the change in the DNA conformation was able to alter the specific interactions observed in the DNA in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>the codon (CTC) normally associated with Leu-93 in the transcortinal polypeptide is altered by this mutation to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>the codon (CTC) usually associated with Leu-93 in transcortinal polypeptide is able to be altered by this mutation to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>the expression and activity of multi-drug resistant carriers is capable of being altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>the expression and activity of multi-drug resistant carriers was able to be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>the expression and activity of multi-drug resistant transporters can be altered by Citocins in cell lines of human hepatomes; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>the expression and activity of multi-drug resistant transporters is able to be altered by Citocins in lines of human hepatoma cells; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>the expression and activity of multi-drug resistant transporters was able to be altered by Citocins in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>the expression and activity of multi-drug resistant transporters will be altered by Citocins in cell lines of human hepatomes; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>the general direction of DNA may be altered by these two berenades in the A4 gene (DVI).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>the general direction of DNA may be altered by these two curves in the A4 gene (DVI).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>the general direction of DNA was altered by these two planes in the A4 gene (DRI).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>the molecular injury associated with s1031 was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>the molecular lesion associated with s1031 made M-NEG (did not alter split and four of the sites could change without loss of activity.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>the molecular lesion associated with s1031 was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>the mutation located in exon 2 , which alters codon (CTC) usually associated with Leu-93 in the transcortinal polypeptide to a codon (CAC) in histidine in the variant genes, is found in exon 2.</text>
                    <arg n="0">the mutation located in exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>the mutation located within exon 2 , which alters codon (CTC) usually associated with Leu-93 in the transcortinal polypeptide to a codon (CAC) in histidine in the variant genes, is found in exon 2.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>the observed DNA specific interactions may be altered by the change in the conformation of DNA in the A4 gene (DVI).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>the overall direction of DNA may be altered by these two planes in the A4 gene (DVI).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>the overall direction of DNA will be altered by these two planes, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>the rate of use of at least 36 carbon sources is altered by without mutation of fruit in the A4 gene (DRI).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>the rates of use of at least 36 carbon sources is altered by a null fruit mutation in the A4 gene (DRI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>the rates of use of at least 36 carbon sources is altered by no fruit mutation in the A4 gene (DVI).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>the specific DNA interactions observed can be altered by the alteration in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>the specific DNA interactions observed was altered by the alteration in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>the specific DNA interactions observed will be altered by the alteration in DNA conformation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>the specific interaction of protein DNA observed can be altered by the alteration of DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>the specific interaction of protein DNA observed is altered by the alteration of DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>the specific interaction of protein DNA observed is altered by the change in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>the specific interaction of protein DNA observed may be altered by the alteration in DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>the specific interaction of protein DNA observed may be altered by the alteration of DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>the specific interaction of protein DNA observed will be altered by the alteration in DNA conformation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>the specific interactions observed in the DNA can be altered by the change in the DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>the specific interactions of protein DNA observed was altered by the alteration of DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>the specific interactions of the DNA observed is altered by the change in the DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>the specific interactions of the observed protein DNA is altered by the alteration of the DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>these two berenades can alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>these two berenades made M-NEG (did not alter the general direction of DNA and four of the sites could change without loss of activity.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>these two berenades was able to alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>these two torso can alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>this mutation can alter vulvar induction in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>this mutation is predicted to alter volvar induction , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>this mutation is predicted to alter vulvular induction , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>this mutation was able to alter volvular induction in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>use rates of at least 36 carbon sources can be altered by a null fruit mutation in the A4 gene (DRI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>use rates of at least 36 carbon sources can be altered by a null mutation fruit in the A4 gene (DRI).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>use rates of at least 36 carbon sources is altered by a nude mutation of fruit in the A4 gene (DVI).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>use rates of at least 36 carbon sources is altered by a null fruit mutation in the A4 gene (DVI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>use rates of at least 36 carbon sources is altered by a null mutation of fruit in the A4 gene (DVI).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>use rates of at least 36 carbon sources may be altered by a null fruit mutation in the A4 gene (DVI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>use rates of at least 36 carbon sources was altered by a null mutation fruit in the A4 gene (DRI).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>use rates of at least 36 carbon sources was altered by without mutation of fruit in the A4 gene (DRI).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>volvar induction was altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>volvar induction will be altered by this mutation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>volvular induction can be altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>vulval induction is altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>vulval induction is altered by this mutation in the A4 gene (DVI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>vulvar induction can be altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>vulvular induction is altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>vulvular induction is altered by this mutation in the A4 gene (DVI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>whether the sites of conserved gt slyclicerosis or ag dinucleotide is able to be altered by four other mutations in DRI gene; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>whether the sites of conserved gt slyclicerosis or ag dinucleotide was able to be altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>whether the sites of conserved gt slyclicerosis or ag dinucleotide was altered by four other mutations in DRI gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>without mutation of fruit made M-NEG (did not alter the rate of use of at least 36 carbon sources and four of the sites could change without loss of activity.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A1 can be altered by cell treatment with insulin-I growth factor , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A1 can be altered by cells treated with an insulin-like growth factor I, and a sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A1 can be altered by coupling variants , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">coupling variants</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A1 can be altered by methylation of prey , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of prey</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A1 can be altered by slice variations, and sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">slice variations</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A1 can be altered by this mutation , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">this mutation</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A1 can be altered by this mutation, and sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">this mutation</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A1 can be altered by treat cells with a growth factor similar to insulin-I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>As Mutations are in opposite directions, the binding phase of the binding sites may not be altered by them (figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>As Mutations were in opposite directions, the binding phase of the binding sites was able to be altered by no (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>As a mechanism are in opposite directions, Bcl-3 expression is not altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>As a mechanism are in opposite directions, Bcl-3 may not be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>As a mechanism are in opposite directions, Bcl-3 will be altered by no by them (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>As a mechanism are in opposite directions, they are non able to alter Bcl-3 expression(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>As a mechanism are in opposite directions, they may alter Bcl-3 expression (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>As a mechanism were in the opposite direction, they alter no to Bcl-3 (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>As cell treatment with a growth factor similar to insulin - I are in opposite directions, PDK1 will be altered by no by them (figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>As cell treatment with a growth factor similar to insulin I are in opposite directions, they are non able to alter PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>As cell treatment with a growth factor similar to insulin I were in opposite directions, PDK1 was able to be altered by no (Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, PDK1 phosphorylation is not altered by them(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, PDK1 phosphorylation may not be altered by them (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, PDK1 phosphorylation may not be altered by them(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, they are non able to alter PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, they may alter PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>As cells treated with an insulin-like growth factor I are in opposite directions, PDK1 is able to be altered by no (Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>As cells treated with an insulin-like growth factor I are in opposite directions, PDK1 is not altered by them (figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>As cells treated with an insulin-like growth factor I are in opposite directions, PDK1 may not be altered by them(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>As cells treated with an insulin-like growth factor I were in the opposite direction, PDK1 was not altered by them(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>As coupling variants are in opposite directions, the protein product may not be altered by them(Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>As cut-variants are in opposite directions, protein product is not altered by them (figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>As cut-variants are in opposite directions, protein product may be not altered by them (figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>As cut-variants are in opposite directions, they are non able to alter protein product(Figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>As cut-variants were in opposite directions, protein product could altered no by them(Figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>As docking variants are in opposite directions, they may alter the protein product (figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>As docking variants were in opposite directions, the protein product was able to be altered by no (Figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>As docking variants were in the opposite direction, the protein product was not altered by them(Figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>As docking variants were in the opposite direction, they alter no to the protein product (figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>As methylation of prey are in opposite directions, they may alter Lrp binding to the GATC1130 site (figure 3C).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>As methylation of prey were in opposite directions, Lrp binding to the GATC1130 site could altered no by them(Figure 3C).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>As methylation of snails were in the opposite direction, they alter no to ligation of Lrp at the GATC1130 site (figure 3C).</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>As mutations are in opposite directions, coupling site is not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>As mutations are in opposite directions, coupling sites is not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>As mutations are in opposite directions, coupling sites is not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>As mutations are in opposite directions, cut-places is not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>As mutations are in opposite directions, cut-places may not be altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>As mutations are in opposite directions, cutoff points may be not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>As mutations are in opposite directions, phase of the binding site may be not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>As mutations are in opposite directions, spill sites may not be altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>As mutations are in opposite directions, spill sites will be altered by no by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>As mutations are in opposite directions, spinning sites is not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>As mutations are in opposite directions, spit sites may not be altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>As mutations are in opposite directions, the phase of the bonding sites is not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>As mutations are in opposite directions, the phase of the bonding sites may not be altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>As mutations are in opposite directions, the phase of the bonding sites may not be altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>As mutations are in opposite directions, the phase of the bonding sites will be altered by no by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>As mutations are in opposite directions, they are non able to alter place of stacking(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>As mutations are in opposite directions, they are non able to alter spit sites(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>As mutations are in opposite directions, they may alter cut place (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>As mutations were in opposite directions, M-NEG could not alter cut-places (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>As mutations were in opposite directions, M-NEG could not alter spinning sites (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>As mutations were in opposite directions, cut place was able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>As mutations were in opposite directions, place of stacking could altered no by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>As mutations were in opposite directions, the phase of the bonding sites was able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>As mutations were in the opposite direction, cutoff points was not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>As mutations were in the opposite direction, place of stacking was not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>As mutations were in the opposite direction, they alter no to spill sites (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>As s1031 is a null allele, we are testing whether Mutations can alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>As s1031 is a null allele, we are testing whether a mechanism can alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>As s1031 is a null allele, we are testing whether cell treatment with insulin-I growth factor can alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>As s1031 is a null allele, we are testing whether coupling variants can alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>As s1031 is a null allele, we are testing whether mutations can alter cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>As s1031 is a null allele, we are testing whether treating cells with a growth factor similar to insulin-I can alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>As s1031 is a null allele, we are testing whether treating cells with a growth factor similar to insulin-I can alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>As slice variations are in opposite directions, protein product is not altered by them(Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>As slice variations are in opposite directions, protein product may be not altered by them (figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>As the molecular injury associated with s1031 are in opposite directions, splicing may not be altered by them (figure 3C).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>As the molecular injury associated with s1031 were in opposite directions, splicing was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>As these two curves are in opposite directions, the general direction of the DNA is able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>As these two curves are in opposite directions, the general direction of the DNA may be not altered by them (figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>As these two curves were in opposite directions, M-NEG could not alter the general direction of the DNA (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>As these two curves were in opposite directions, the general direction of the DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>As these two curves were in the opposite direction, the general direction of the DNA was not altered by them(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation is able to be altered by no (Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation with PPDK1 may not be altered by them (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, they are non able to alter phosphorylation with PPDK1(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, they may alter PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, they may alter phosphorylation with PPDK1 (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>As treat cells with a growth factor similar to insulin-I were in opposite directions, PDK1 phosphorylation could altered no by them(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>As treat cells with a growth factor similar to insulin-I were in opposite directions, phosphorylation with PPDK1 could altered no by them(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation of PDK1 is able to be altered by no (Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, they may alter PDK1 phosphatation (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>As treatment of cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation is able to be altered by no (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>As treatment of cells with a growth factor similar to insulin-I were in opposite directions, PDK1 phosphorylation was able to be altered by no (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>As treatment of cells with insulin-like growth factor I are in opposite directions, PDK1 phosphorylation is not altered by them (figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>As treatment of cells with insulin-like growth factor I are in opposite directions, PDK1 phosphorylation may not be altered by them(Figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>As treatment of cells with insulin-like growth factor I are in opposite directions, they are non able to alter PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>As treatment of cells with insulin-like growth factor I were in the opposite direction, they alter no to PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>In addition, Mutations altered the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>In addition, Mutations altered the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>In addition, Mutations is able to alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>In addition, Mutations will be able to alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In addition, a mechanism altered Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In addition, a mechanism can alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In addition, a mechanism may be able to alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In addition, a mechanism may be able to alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>In addition, cell treatment with a growth factor similar to insulin - I altered PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>In addition, cell treatment with a growth factor similar to insulin - I will be able to alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>In addition, cell treatment with a growth factor similar to insulin I altered PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>In addition, cell treatment with a growth factor similar to insulin I can alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>In addition, cell treatment with a growth factor similar to insulin I will alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>In addition, cell treatment with insulin-I growth factor could alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>In addition, cell treatment with insulin-I growth factor is able to alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>In addition, cell treatment with insulin-I growth factor is able to alter phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>In addition, cell treatment with insulin-I growth factor may alter phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>In addition, cells treated with an insulin-like growth factor I will be able to alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>In addition, coupling variants alters the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>In addition, coupling variants may alter protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>In addition, coupling variants may be able to alter protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>In addition, cut-variants may alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>In addition, cut-variants may be able to alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>In addition, methylation of prey alters Lrp binding to the GATC1130 site.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>In addition, methylation of snails will be able to alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>In addition, mutations altered coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>In addition, mutations alters cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>In addition, mutations can alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>In addition, mutations can alter cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>In addition, mutations can alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>In addition, mutations could alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>In addition, mutations is able to alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>In addition, mutations may alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>In addition, mutations may be able to alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>In addition, mutations may be able to alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>In addition, mutations may be able to alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>In addition, mutations may be able to alter spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>In addition, mutations may be able to alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>In addition, mutations will alter coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>In addition, mutations will alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>In addition, mutations will be able to alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>In addition, mutations will be able to alter cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>In addition, slice variations is able to alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>In addition, slice variations may alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>In addition, the molecular injury associated with s1031 will alter splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>In addition, these two curves is able to alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>In addition, these two curves may be able to alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>In addition, these two trunks will be able to alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>In addition, treat cells with a growth factor similar to insulin-I could alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>In addition, treating cells with a growth factor similar to insulin-I can alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>In addition, treating cells with a growth factor similar to insulin-I can alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>In addition, treating cells with a growth factor similar to insulin-I could alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>In addition, treating cells with a growth factor similar to insulin-I may alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>In addition, treating cells with a growth factor similar to insulin-I may be able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I alters phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I can alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>In addition, treatment of cells with insulin-like growth factor I may be able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>In protein coding transcripts, Bcl-3 can be altered in 79% of a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>In protein coding transcripts, Bcl-3 expression can be altered in 79% of a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>In protein coding transcripts, Bcl-3 expression is altered by 79% of a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>In protein coding transcripts, PDK1 phosphorylation can be altered in 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>In protein coding transcripts, PDK1 phosphorylation could be altered by 79% of treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>In protein coding transcripts, PDK1 phosphorylation is able to be altered in 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>In protein coding transcripts, PDK1 phosphorylation is able to be altered in 79% of treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>In protein coding transcripts, PDK1 phosphorylation was altered by 79% of treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>In protein coding transcripts, PDK1 will be altered by 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>In protein coding transcripts, coupling site is able to be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>In protein coding transcripts, coupling sites was altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>In protein coding transcripts, coupling sites will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>In protein coding transcripts, ligation of Lrp at the GATC1130 site can be altered in 79% of methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>In protein coding transcripts, ligation of Lrp at the GATC1130 site is altered by 79% of methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>In protein coding transcripts, phase of the binding site is altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>In protein coding transcripts, phosphorylation of PDK1 could be altered by 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>In protein coding transcripts, phosphorylation of PDK1 is able to be altered in 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>In protein coding transcripts, phosphorylation of PDK1 was altered by 79% of treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>In protein coding transcripts, phosphorylation with PPDK1 can be altered in 79% of treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>In protein coding transcripts, phosphorylation with PPDK1 was altered by 79% of treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>In protein coding transcripts, protein product can be altered in 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>In protein coding transcripts, protein product was altered by 79% of slice variations.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>In protein coding transcripts, protein product will be altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>In protein coding transcripts, spill sites could be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>In protein coding transcripts, spinning sites is altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>In protein coding transcripts, spinning sites will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>In protein coding transcripts, spit sites could be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>In protein coding transcripts, the binding phase of the binding sites could be altered by 79% of Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>In protein coding transcripts, the phase of binding of the binding sites is altered by 79% of Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>In protein coding transcripts, the protein product will be altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>It is predicted that A1 will be altered by cell treatment with a growth factor similar to insulin - I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>It is predicted that A1 will be altered by cell treatment with a growth factor similar to insulin I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>It is predicted that A1 will be altered by mutations , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>It is predicted that A1 will be altered by these two curves , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two curves</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>It is predicted that A1 will be altered by treat cells with a growth factor similar to insulin-I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>It is predicted that A1 will be altered by treatment of cells with insulin-like growth factor I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>It is predicted that Mutations can alter the binding phase of the binding sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>It is predicted that a mechanism can alter Bcl-3 expression , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>It is predicted that cut-variants will be able to alter protein product , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>It is predicted that methylation of prey will be able to alter Lrp binding to the GATC1130 site , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>It is predicted that mutations can alter cutoff points, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>It is predicted that mutations can alter the phase of the bonding sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>It is predicted that mutations will be able to alter coupling site , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>It is predicted that mutations will be able to alter cut-places , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>It is predicted that the molecular injury associated with s1031 can alter splicing , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>It is predicted that these two trunks will be able to alter the general direction of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>It is predicted that treating cells with a growth factor similar to insulin-I will be able to alter PDK1 phosphorylation , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>It is predicted that treating cells with a growth factor similar to insulin-I will be able to alter phosphorylation of PDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>It is predicted that treatment of cells with a growth factor similar to insulin-I will be able to alter phosphorylation with PPDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Lrp binding to the GATC1130 site can be altered by methylation of prey in the A4 gene (DRI).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Mutations was able to alter the phase of binding of the binding sites in the A4 gene (DRI).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>PDK1 may be altered by cell treatment with insulin-I growth factor in the A4 gene (DVI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>PDK1 phosphorylation can be altered by treat cells with a growth factor similar to insulin-I in the A4 gene (DRI).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>PDK1 phosphorylation is altered by treatment of cells with a growth factor similar to insulin-I in the A4 gene (DRI).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>PDK1 phosphorylation is altered by treatment of cells with insulin-like growth factor I in the A4 gene (DVI).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>PDK1 phosphorylation may be altered by cell treatment with insulin-I growth factor in the A4 gene (DVI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>PDK1 phosphorylation was altered by cell treatment with insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>PDK1 phosphorylation was altered by treat cells with a growth factor similar to insulin-I in the A4 gene (DRI).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>PDK1 phosphorylation will be altered by treatment of cells with a growth factor similar to insulin-I, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>PDK1 was altered by cell treatment with insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Since Mutations are in opposite directions, the binding phase of the binding sites can be not altered by them (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Since Mutations are in opposite directions, the binding phase of the binding sites will be altered by not by them (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Since Mutations are in opposite directions, the phase of binding of the binding sites can be not altered by them (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Since Mutations are in opposite directions, they are not capable of altering the binding phase of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Since Mutations are in opposite directions, they are not capable of altering the phase of binding of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>Since Mutations were in opposite directions, they were not capable of altering the binding phase of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>Since a mechanism are in opposite directions, Bcl-3 will be altered by not by them (Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>Since a mechanism were in opposite directions, they altered no Bcl-3 expression(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>Since cell treatment with a growth factor similar to insulin - I were in the opposite direction, PDK1 was not altered by them (Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, PDK1 phosphorylation can be not altered by them (Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, PDK1 will be altered by not by them (Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, they are not capable of altering PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Since cell treatment with insulin-I growth factor were in opposite directions, they were not capable of altering PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>Since cells treated with an insulin-like growth factor I were in opposite directions, PDK1 could not be altered by them (Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>Since coupling variants were in opposite directions, the protein product could not be altered by them (Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>Since coupling variants were in the opposite direction, the protein product was not altered by them (Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>Since docking variants are in opposite directions, they are not capable of altering the protein product(Figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>Since docking variants are in opposite directions, they will alter no the protein product (figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>Since methylation of prey were in opposite directions, they were not capable of altering Lrp binding to the GATC1130 site (figure 3C).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>Since methylation of prey were in the opposite direction, Lrp binding to the GATC1130 site was not altered by them (Figure 3C).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>Since mutations are in opposite directions, cut-places will be altered by not by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>Since mutations are in opposite directions, they will alter no spill sites (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Since mutations were in opposite directions, cut-places could not be altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Since mutations were in opposite directions, they altered no spit sites(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Since mutations were in opposite directions, they were not capable of altering cut place (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Since mutations were in opposite directions, they were not capable of altering cutoff points (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Since mutations were in opposite directions, they were not capable of altering place of stacking(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>Since mutations were in opposite directions, they were not capable of altering spill sites (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>Since mutations were in opposite directions, they were not capable of altering the phase of the bonding sites(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>Since mutations were in the opposite direction, cut-places was not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>Since mutations were in the opposite direction, cutoff points was not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>Since mutations were in the opposite direction, spit sites was not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>Since s1031 is a null allele, we are testing whether Bcl-3 expression can be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>Since s1031 is a null allele, we are testing whether Bcl-3 is altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>Since s1031 is a null allele, we are testing whether Mutations will alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism will alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>Since s1031 is a null allele, we are testing whether coupling sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>Since s1031 is a null allele, we are testing whether cut-places is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>Since s1031 is a null allele, we are testing whether phosphorylation of PDK1 is altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>Since s1031 is a null allele, we are testing whether protein product can be altered by cut-variants.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>Since s1031 is a null allele, we are testing whether the molecular injury associated with s1031 will alter splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>Since s1031 is a null allele, we are testing whether the phase of binding of the binding sites is altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>Since s1031 is a null allele, we are testing whether the phase of the bonding sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>Since s1031 is a null allele, we are testing whether the protein product can be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>Since s1031 is a null allele, we are testing whether the protein product is altered by docking variants.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>Since s1031 is a null allele, we have checked whether Bcl-3 expression can be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>Since s1031 is a null allele, we have checked whether Lrp binding to the GATC1130 site is altered by methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>Since s1031 is a null allele, we have checked whether Lrp binding to the GATC1130 site was able to be altered by methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>Since s1031 is a null allele, we have checked whether Mutations can alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>Since s1031 is a null allele, we have checked whether Mutations is altering the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>Since s1031 is a null allele, we have checked whether Mutations is altering the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>Since s1031 is a null allele, we have checked whether Mutations was able to alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 is altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 is altered by cells treated with an insulin-like growth factor I.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphatation can be altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation can be altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation was able to be altered by treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 was able to be altered by cells treated with an insulin-like growth factor I.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 was altered by cell treatment with a growth factor similar to insulin I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 was altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>Since s1031 is a null allele, we have checked whether a mechanism has altered Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with insulin-I growth factor can alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with insulin-I growth factor was able to alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>Since s1031 is a null allele, we have checked whether coupling sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>Since s1031 is a null allele, we have checked whether coupling sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>Since s1031 is a null allele, we have checked whether coupling variants is altering the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>Since s1031 is a null allele, we have checked whether cut place is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>Since s1031 is a null allele, we have checked whether cut-variants would alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>Since s1031 is a null allele, we have checked whether cutoff points was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>Since s1031 is a null allele, we have checked whether mutations can alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>Since s1031 is a null allele, we have checked whether mutations can alter cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>Since s1031 is a null allele, we have checked whether mutations is altering coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>Since s1031 is a null allele, we have checked whether mutations is altering spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>Since s1031 is a null allele, we have checked whether mutations was able to alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>Since s1031 is a null allele, we have checked whether mutations would alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>Since s1031 is a null allele, we have checked whether phase of the binding site was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>Since s1031 is a null allele, we have checked whether phosphorylation of PDK1 can be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>Since s1031 is a null allele, we have checked whether phosphorylation of PDK1 is altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>Since s1031 is a null allele, we have checked whether phosphorylation of PDK1 was altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>Since s1031 is a null allele, we have checked whether phosphorylation with PPDK1 is altered by treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>Since s1031 is a null allele, we have checked whether protein product can be altered by slice variations.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>Since s1031 is a null allele, we have checked whether protein product is altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>Since s1031 is a null allele, we have checked whether splicing was able to be altered by the molecular injury associated with s1031.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA can be altered by these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA was altered by these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>Since s1031 is a null allele, we have checked whether the phase of the bonding sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>Since s1031 is a null allele, we have checked whether the protein product can be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>Since s1031 is a null allele, we have checked whether these two trunks can alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>Since s1031 is a null allele, we have checked whether these two trunks is altering the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>Since s1031 is a null allele, we have checked whether treat cells with a growth factor similar to insulin-I would alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I has altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I is altering phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I was able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I would alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with insulin-like growth factor I can alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with insulin-like growth factor I has altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>Since s1031 is a null allele, we tested whether Bcl-3 expression is able to be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>Since s1031 is a null allele, we tested whether Lrp binding to the GATC1130 site was able to be altered by methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>Since s1031 is a null allele, we tested whether Mutations is able to alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>Since s1031 is a null allele, we tested whether Mutations is able to alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>Since s1031 is a null allele, we tested whether PDK1 phosphorylation is able to be altered by treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>Since s1031 is a null allele, we tested whether cells treated with an insulin-like growth factor I is able to alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>Since s1031 is a null allele, we tested whether coupling site is able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>Since s1031 is a null allele, we tested whether coupling variants is able to alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>Since s1031 is a null allele, we tested whether coupling variants was able to alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>Since s1031 is a null allele, we tested whether cutoff points was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>Since s1031 is a null allele, we tested whether methylation of snails is able to alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>Since s1031 is a null allele, we tested whether mutations is able to alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>Since s1031 is a null allele, we tested whether mutations is able to alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>Since s1031 is a null allele, we tested whether mutations is able to alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>Since s1031 is a null allele, we tested whether the binding phase of the binding sites is able to be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>Since s1031 is a null allele, we tested whether the protein product is able to be altered by docking variants.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>Since s1031 is a null allele, we tested whether the protein product was able to be altered by docking variants.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>Since s1031 is a null allele, we tested whether these two trunks was able to alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>Since slice variations are in opposite directions, protein product can be not altered by them (Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>Since slice variations were in opposite directions, they altered no protein product(Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>Since slice variations were in the opposite direction, protein product was not altered by them (Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>Since these two curves are in opposite directions, the general direction of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>Since these two curves are in opposite directions, the general direction of the DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>Since these two curves are in opposite directions, they are not capable of altering the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>Since these two curves were in opposite directions, they altered no the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>Since these two trunks are in opposite directions, they will alter no the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>Since these two trunks were in opposite directions, they altered no the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>Since treating cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphatation will be altered by not by them (Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>Since treating cells with a growth factor similar to insulin-I are in opposite directions, they are not capable of altering phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>Since treating cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering PDK1 phosphatation(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>Since treating cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering phosphorylation of PDK1 (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>Since treating cells with a growth factor similar to insulin-I were in the opposite direction, PDK1 phosphatation was not altered by them (Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>Since treatment of cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation with PPDK1 will be altered by not by them (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>Since treatment of cells with a growth factor similar to insulin-I were in opposite directions, PDK1 phosphorylation could not be altered by them (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>Since treatment of cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>Since treatment of cells with a growth factor similar to insulin-I were in the opposite direction, PDK1 phosphorylation was not altered by them (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>Since treatment of cells with insulin-like growth factor I were in opposite directions, they were not capable of altering PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>Since treatment of cells with insulin-like growth factor I were in the opposite direction, PDK1 phosphorylation was not altered by them (Figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to Mutations, which has been able to suddenly alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with a growth factor similar to insulin I, which has been able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with insulin-I growth factor, which has been able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to cells treated with an insulin-like growth factor I, which has been able to suddenly alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to methylation of snails, which has been able to suddenly alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which has been able to suddenly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to slice variations, which has been able to suddenly alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which has been able to suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with a growth factor similar to insulin-I, which has been able to suddenly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to Mutations, which can subtly alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a mechanism, which can subtly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a mechanism, which is able to subtly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a mechanism, which was able to subtly alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to cell treatment with insulin-I growth factor, which can subtly alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to cells treated with an insulin-like growth factor I, which is able to subtly alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to methylation of prey, which can be able to subtly alter Lrp binding to the GATC1130 site.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which can subtly alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which is able to subtly alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the molecular injury associated with s1031, which was able to subtly alter splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two curves, which can be able to subtly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two curves, which can subtly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two trunks, which can be able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treat cells with a growth factor similar to insulin-I, which can be able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which can be able to subtly alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which was able to subtly alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to a mechanism, which subtly altered Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to slice variations, which subtly altered protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which subtly altered PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to treatment of cells with a growth factor similar to insulin-I, which subtly altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 can be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 phosphorylation can be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 phosphorylation can be altered by treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 phosphorylation can be altered by treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 phosphorylation can be altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as coupling site are able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as coupling sites are able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as ligation of Lrp at the GATC1130 site can be altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as protein product are able to be altered by cut-variants.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as protein product can be altered by slice variations.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as spill sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the binding phase of the binding sites are able to be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the general direction of the DNA are able to be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the protein product are able to be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations can subtly alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations is able to subtly alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations may suddenly alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations subtly altered the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations subtly alters the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism may be able to suddenly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism may suddenly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism suddenly alters Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with a growth factor similar to insulin I may be able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with a growth factor similar to insulin I subtly altered PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor can be able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor can be able to subtly alter phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor is able to suddenly alter phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor subtly altered PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor subtly altered PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cells treated with an insulin-like growth factor I can subtly alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cells treated with an insulin-like growth factor I is able to subtly alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling variants can subtly alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling variants suddenly altered protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling variants suddenly alters protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants can subtly alter the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants subtly alters the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants suddenly alters the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because methylation of snails may be able to suddenly alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations can be able to subtly alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations can subtly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations can subtly alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to subtly alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to subtly alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to subtly alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to suddenly alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to suddenly alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may be able to suddenly alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may be able to suddenly alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may suddenly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may suddenly alter phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations suddenly altered coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations suddenly alters cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations suddenly alters place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because slice variations is able to subtly alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular injury associated with s1031 can be able to subtly alter splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two curves may suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks can subtly alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks may be able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks subtly alters the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks suddenly alters the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treat cells with a growth factor similar to insulin-I can be able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treat cells with a growth factor similar to insulin-I suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I is able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I subtly altered phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I suddenly altered PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I suddenly alters PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I suddenly alters PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I suddenly alters phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I can be able to subtly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I is able to subtly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I may suddenly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I suddenly altered phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I suddenly alters phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with insulin-like growth factor I is able to suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with insulin-like growth factor I subtly altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with insulin-like growth factor I suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to Mutations, which suddenly altered the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a mechanism, which is able to suddenly alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a mechanism, which may be able to suddenly alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with a growth factor similar to insulin I, which suddenly altered PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with insulin-I growth factor, which can suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cells treated with an insulin-like growth factor I, which suddenly altered PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to coupling variants, which is able to suddenly alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to methylation of snails, which suddenly altered ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which can suddenly alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which can suddenly alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which is able to suddenly alter spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which is able to suddenly alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which may be able to suddenly alter coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which may be able to suddenly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which may be able to suddenly alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which may be able to suddenly alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which suddenly altered cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which can suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which is able to suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which may be able to suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treat cells with a growth factor similar to insulin-I, which is able to suddenly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treat cells with a growth factor similar to insulin-I, which may be able to suddenly alter phosphorylation with PPDK1.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which can suddenly alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which is able to suddenly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with insulin-like growth factor I, which may be able to suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 could be altered by cell treatment with a growth factor similar to insulin - I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 could be altered by cell treatment with a growth factor similar to insulin I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 could be altered by cells treated with an insulin-like growth factor I.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 phosphorylation can be altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 phosphorylation could be altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 phosphorylation is altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 phosphorylation was altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 was altered by cell treatment with a growth factor similar to insulin - I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 was altered by cells treated with an insulin-like growth factor I.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since coupling sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since cut place was altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since phase of the binding site could be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since protein product could be altered by slice variations.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spill sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spill sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spinning sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the general direction of DNA was altered by these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the phase of binding of the binding sites was altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the protein product could be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since Bcl-3 is altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since Lrp binding to the GATC1130 site is altered by methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since Lrp binding to the GATC1130 site may be altered by methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since PDK1 phosphorylation is altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since PDK1 phosphorylation may be altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since PDK1 phosphorylation may be altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since coupling site may be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since cut place is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since cut-places may be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since protein product is altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since spill sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the general direction of the DNA may be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the phase of the bonding sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the protein product is altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the protein product is altered by docking variants.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>We believe that Mutations is capable of altering the binding phase of the binding sites, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>We believe that cell treatment with insulin-I growth factor is able to alter PDK1 phosphorylation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>We believe that mutations is able to alter cutoff points, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>We believe that mutations is able to alter the phase of the bonding sites, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>We believe that these two trunks is capable of altering the general direction of DNA, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>We believe that treating cells with a growth factor similar to insulin-I is capable of altering PDK1 phosphorylation, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>We believe that treatment of cells with a growth factor similar to insulin-I is able to alter PDK1 phosphorylation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>We believe that treatment of cells with a growth factor similar to insulin-I is able to alter phosphorylation with PPDK1, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>We believe that treatment of cells with insulin-like growth factor I is able to alter PDK1 phosphorylation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>a mechanism can alter Bcl-3 expression in the A4 gene (DRI).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>a mechanism made M-NEG (did not alter Bcl-3 expression and four of the sites could change without loss of activity.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>cell treatment with a growth factor similar to insulin - I can alter PDK1 in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>cell treatment with insulin-I growth factor is predicted to alter PDK1 phosphorylation , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>cells treated with an insulin-like growth factor I was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>coupling sites can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>coupling sites is altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>coupling sites may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>coupling variants was able to alter protein product in the A4 gene (DRI).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>cut place can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>cut place will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>cut-places can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>cut-places may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>cut-places will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>docking variants was able to alter the protein product in the A4 gene (DRI).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>docking variants was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">docking variants</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>ligation of Lrp at the GATC1130 site is altered by methylation of snails in the A4 gene (DRI).</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>methylation of prey is predicted to alter Lrp binding to the GATC1130 site , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>mutations can alter cut place in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>mutations can alter cut-places in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>mutations is predicted to alter spinning sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>mutations was able to alter cut-places in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>mutations was able to alter the phase of the bonding sites in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>phase of the binding site is altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>phosphorylation of PDK1 is altered by cell treatment with insulin-I growth factor in the A4 gene (DVI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>phosphorylation of PDK1 may be altered by cell treatment with insulin-I growth factor in the A4 gene (DVI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>phosphorylation with PPDK1 will be altered by treatment of cells with a growth factor similar to insulin-I, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>prey methylation is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">prey methylation</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>prey methylation is located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in variant genes.</text>
                    <arg n="0">prey methylation</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>protein product is altered by slice variations in the A4 gene (DRI).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>protein product is altered by slice variations in the A4 gene (DVI).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>slice variations is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">slice variations</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>slice variations was able to alter protein product in the A4 gene (DRI).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>spill sites can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>spill sites may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>spinning sites is altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>the binding phase of the binding sites is altered by Mutations in the A4 gene (DVI).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>the molecular injury associated with s1031 made M-NEG (did not alter splicing and four of the sites could change without loss of activity.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>the phase of binding of the binding sites can be altered by Mutations in the A4 gene (DRI).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>the phase of binding of the binding sites will be altered by Mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>the phase of the bonding sites can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>the phase of the bonding sites may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>the protein product can be altered by docking variants in the A4 gene (DRI).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>these two curves is predicted to alter the general direction of the DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>these two trunks is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">these two trunks</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>treat cells with a growth factor similar to insulin-I made M-NEG (did not alter phosphorylation with PPDK1 and four of the sites could change without loss of activity.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>treating cells with a growth factor similar to insulin-I can alter PDK1 phosphorylation in the A4 gene (DRI).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>treating cells with a growth factor similar to insulin-I is predicted to alter phosphorylation of PDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>treatment of cells with a growth factor similar to insulin-I is predicted to alter phosphorylation with PPDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>treatment of cells with insulin-like growth factor I was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
